The impact of eicosanoids on the crosstalk between innate and adaptive immunity: The key roles of dendritic cells

Tissue Antigens

Volumn 65, Issue 6, 2005, Pages 507-514

  Harizi, Hedi ^a,b   Gualde, N ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

Author keywords

Cytokines; DC; Eicosanoids; Immunity; Inflammatory response

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; CYTOKINE; ICOSANOID; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPID; PATTERN RECOGNITION RECEPTOR; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTANOID; RECEPTOR; TISSUE ANTIGEN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CYTOKINE RELEASE; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MEDIATOR RELEASE; MOLECULAR INTERACTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ARACHIDONIC ACID; CYTOKINES; DENDRITIC CELLS; EICOSANOIDS; HUMANS; IMMUNE SYSTEM; IMMUNITY, NATURAL; INFLAMMATION; LIPID METABOLISM; LYMPHOCYTES; MACROPHAGES; MODELS, BIOLOGICAL; PHAGOCYTOSIS; PROSTAGLANDINS;

EID: 20144370418     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00394.x     Document Type: Review

References (50)

1. Clark GJ, Angel N, Kato M et al. The role of dendritic cells in the innate immune system. Microbes Infect 2000: 3: 257-72.
2. Palucka K, Banchereau J. How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr Opin Immunol 2002: 14: 420-31.
3. Banchereau J, Steinman RM. The dendritic cell and the control of immunity. Nature 1998: 392: 245-52.
4. 2 that contributes to the immunomodulation induced by antigen-presenting cells. Cell Immunol 2001: 209: 19-28.
5. 4 receptor subtypes. J Leukoc Biol 2003: 73: 756-63.
6. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 2002: 168: 2255-63.
7. 4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci USA 1996: 93: 10978-83.
8. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002: 99: 351-8.
9. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J Exp Med 1995: 182: 389-400.
10. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997: 388: 782-7.
11. Sallusto F, Palermo B, Lenig D et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999: 29: 1617-25.
12. 2. Blood 2004: 103: 1595-601.
13. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000: 103: 757-38.
14. Okunishi K, Dohi M, Nakagome K, Tanaka R, Yamamoto K. A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J Immunol 2004: 173: 6393-402.
15. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001: 294: 1871-5.
16. 2-induced DL-10 in bone marrow-derived dendritic cells. Cell Immunol 2004: 228: 99-109.
17. 4 production from dendritic cells via an DL-10-dependent mechanism. J Immunol 2003: 170: 139-46.
18. Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991: 12: 349-52.
19. Juzan M, Hostein I, Gualde N. Role of thymus-eicosanoids in the immune response. Prostaglandins Leukot Essent Fatty Acids 1992: 46: 247-55.
20. + T cells. J Immunol 1996: 156: 1722-7.
21. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 2001: 166: 249-55.
22. 2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995: 181: 775-9.
23. 2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997: 159: 28-35.
24. 2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology 2004: 111: 298-305.
25. 2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol 2003: 223: 120-32.
26. 2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells. J Leukoc Biol 2003: 74: 868-79.
27. 2 regulates the migratory capacity of specific DC subsets. Blood 2002: 100: 1362-72.
28. 2 that regulate cellular immune responses in the mouse. J Clin Invest 2001: 108: 1229-35.
29. 4 receptor. J Biol Chem 2002: 277: 44147-54.
30. 2 promotes the survival of bone marrow-derived dendritic cells. J Immunol 2004: 173: 6955-64.
31. 2. J Biol Chem 2004: 279: 55176-86.
32. 4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 2003: 9: 744-9.
33. 2 receptor. J Clin Invest 2003: 111: 727-35.
34. 2-mediated regulation of mast cell degranulation and IL-6 production. J Immunol 2002: 169: 4586-93.
35. 2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol 2003: 4: 694-701.
36. Bella SD, Molteni M, Mocellin C, Fumagalli S, Bonara P, Scorza R. Novel mode of action of iloprost: in vitro down-regulation of endothelial cell adhesion molecules. Prostaglandins Other Lipid Mediat 2001: 65: 73-83.
37. 2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J Immunol 2003: 171: 3936-40.
38. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 2001: 193: 1135-47.
39. 2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001: 108: 982-8.
40. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001: 193: 255-61.
41. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001: 98: 1942-8.
42. 2-like and eotaxin-like selective responses in eosinophils and basophils. J Biol Chem 2002: 277: 26012-20.
43. 2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides. J Exp Med 1994: 180: 1967-72.
44. Thomas DW, Rocha PN, Nataraj C et al. Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. J Immunol 2003: 171: 6389-95.
45. Ruiz P, Coffman TM, Klotman PE et al. Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts. Transplantation 1989: 48: 660-6.
46. Nencioni A, Lauber K, Grunebach F et al. Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. Exp Hematol 2002: 30: 1020-8.
47. Azuma Y, Shinohara M, Wang PL, Ohura K. 15-Deoxy-delta (12,14)-prostaglandin J (2) inhibits IL-10 and IL-12 production by macrophages. Biochem Biophys Res Commun 2001: 283: 344-6.
48. 4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 2003: 4: 965-73.
49. Busse WW. Leukotrienes and inflammation. Am J Respir Crit Care Med 1998: 157: 210-3.
50. Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A. Lipoxin-mediated inhibition of IL-12 production by DC: a mechanism for regulation of microbial immunity. Nat Immunol 2002: 3: 76-82.